0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Single Cancer Screening Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-7V18804
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Single Cancer Screening Market Research Report 2024
BUY CHAPTERS

Global Single Cancer Screening Market Research Report 2024

Code: QYRE-Auto-7V18804
Report
November 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Single Cancer Screening Market Size

The global Single Cancer Screening market was valued at US$ 1242 million in 2023 and is anticipated to reach US$ 2961 million by 2030, witnessing a CAGR of 13.5% during the forecast period 2024-2030.

Single Cancer Screening Market

Single Cancer Screening Market

Single cancer screening refers to screening procedures focused on a specific type of cancer, aimed at early detection to improve treatment outcomes and survival rates. This type of screening typically includes specific tests for certain cancers, such as mammography for breast cancer, Pap smears for cervical cancer, or blood tests for prostate cancer. The implementation of single cancer screening helps identify high-risk populations and provides timely interventions, effectively reducing cancer-related mortality.
North American market for Single Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Single Cancer Screening in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Single Cancer Screening include Grail, Exact Sciences, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical, Genetron Health, New Horizon Health, Burning Rock, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cancer Screening.
The Single Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Single Cancer Screening Market Report

Report Metric Details
Report Name Single Cancer Screening Market
Accounted market size in 2023 US$ 1242 million
Forecasted market size in 2030 US$ 2961 million
CAGR 13.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Grail, Exact Sciences, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Single Cancer Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Single Cancer Screening Market growing?

Ans: The Single Cancer Screening Market witnessing a CAGR of 13.5% during the forecast period 2024-2030.

What is the Single Cancer Screening Market size in 2030?

Ans: The Single Cancer Screening Market size in 2030 will be US$ 2961 million.

Who are the main players in the Single Cancer Screening Market report?

Ans: The main players in the Single Cancer Screening Market are Grail, Exact Sciences, Oncognostic, Epigenomics, Abbott, Qiagen, iStat Biomedical, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology

What are the Application segmentation covered in the Single Cancer Screening Market report?

Ans: The Applications covered in the Single Cancer Screening Market report are Hospital, Physical Examination Center, Other

What are the Type segmentation covered in the Single Cancer Screening Market report?

Ans: The Types covered in the Single Cancer Screening Market report are Colorectal Cancer, Liver Cancer, Lung Cancer, Other

Recommended Reports

Cancer Diagnostics

Screening Technologies

Therapy & Personalized Medicine

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cancer Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Single Cancer Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Physical Examination Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Cancer Screening Market Perspective (2019-2030)
2.2 Global Single Cancer Screening Growth Trends by Region
2.2.1 Global Single Cancer Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Single Cancer Screening Historic Market Size by Region (2019-2024)
2.2.3 Single Cancer Screening Forecasted Market Size by Region (2025-2030)
2.3 Single Cancer Screening Market Dynamics
2.3.1 Single Cancer Screening Industry Trends
2.3.2 Single Cancer Screening Market Drivers
2.3.3 Single Cancer Screening Market Challenges
2.3.4 Single Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cancer Screening Players by Revenue
3.1.1 Global Top Single Cancer Screening Players by Revenue (2019-2024)
3.1.2 Global Single Cancer Screening Revenue Market Share by Players (2019-2024)
3.2 Global Single Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Single Cancer Screening Revenue
3.4 Global Single Cancer Screening Market Concentration Ratio
3.4.1 Global Single Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cancer Screening Revenue in 2023
3.5 Global Key Players of Single Cancer Screening Head office and Area Served
3.6 Global Key Players of Single Cancer Screening, Product and Application
3.7 Global Key Players of Single Cancer Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Cancer Screening Breakdown Data by Type
4.1 Global Single Cancer Screening Historic Market Size by Type (2019-2024)
4.2 Global Single Cancer Screening Forecasted Market Size by Type (2025-2030)
5 Single Cancer Screening Breakdown Data by Application
5.1 Global Single Cancer Screening Historic Market Size by Application (2019-2024)
5.2 Global Single Cancer Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Single Cancer Screening Market Size (2019-2030)
6.2 North America Single Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Single Cancer Screening Market Size by Country (2019-2024)
6.4 North America Single Cancer Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Cancer Screening Market Size (2019-2030)
7.2 Europe Single Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Single Cancer Screening Market Size by Country (2019-2024)
7.4 Europe Single Cancer Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Cancer Screening Market Size (2019-2030)
8.2 Asia-Pacific Single Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Single Cancer Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Single Cancer Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single Cancer Screening Market Size (2019-2030)
9.2 Latin America Single Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Single Cancer Screening Market Size by Country (2019-2024)
9.4 Latin America Single Cancer Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cancer Screening Market Size (2019-2030)
10.2 Middle East & Africa Single Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Single Cancer Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Single Cancer Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grail
11.1.1 Grail Company Details
11.1.2 Grail Business Overview
11.1.3 Grail Single Cancer Screening Introduction
11.1.4 Grail Revenue in Single Cancer Screening Business (2019-2024)
11.1.5 Grail Recent Development
11.2 Exact Sciences
11.2.1 Exact Sciences Company Details
11.2.2 Exact Sciences Business Overview
11.2.3 Exact Sciences Single Cancer Screening Introduction
11.2.4 Exact Sciences Revenue in Single Cancer Screening Business (2019-2024)
11.2.5 Exact Sciences Recent Development
11.3 Oncognostic
11.3.1 Oncognostic Company Details
11.3.2 Oncognostic Business Overview
11.3.3 Oncognostic Single Cancer Screening Introduction
11.3.4 Oncognostic Revenue in Single Cancer Screening Business (2019-2024)
11.3.5 Oncognostic Recent Development
11.4 Epigenomics
11.4.1 Epigenomics Company Details
11.4.2 Epigenomics Business Overview
11.4.3 Epigenomics Single Cancer Screening Introduction
11.4.4 Epigenomics Revenue in Single Cancer Screening Business (2019-2024)
11.4.5 Epigenomics Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Single Cancer Screening Introduction
11.5.4 Abbott Revenue in Single Cancer Screening Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Single Cancer Screening Introduction
11.6.4 Qiagen Revenue in Single Cancer Screening Business (2019-2024)
11.6.5 Qiagen Recent Development
11.7 iStat Biomedical
11.7.1 iStat Biomedical Company Details
11.7.2 iStat Biomedical Business Overview
11.7.3 iStat Biomedical Single Cancer Screening Introduction
11.7.4 iStat Biomedical Revenue in Single Cancer Screening Business (2019-2024)
11.7.5 iStat Biomedical Recent Development
11.8 Genetron Health
11.8.1 Genetron Health Company Details
11.8.2 Genetron Health Business Overview
11.8.3 Genetron Health Single Cancer Screening Introduction
11.8.4 Genetron Health Revenue in Single Cancer Screening Business (2019-2024)
11.8.5 Genetron Health Recent Development
11.9 New Horizon Health
11.9.1 New Horizon Health Company Details
11.9.2 New Horizon Health Business Overview
11.9.3 New Horizon Health Single Cancer Screening Introduction
11.9.4 New Horizon Health Revenue in Single Cancer Screening Business (2019-2024)
11.9.5 New Horizon Health Recent Development
11.10 Burning Rock
11.10.1 Burning Rock Company Details
11.10.2 Burning Rock Business Overview
11.10.3 Burning Rock Single Cancer Screening Introduction
11.10.4 Burning Rock Revenue in Single Cancer Screening Business (2019-2024)
11.10.5 Burning Rock Recent Development
11.11 Berry Oncology
11.11.1 Berry Oncology Company Details
11.11.2 Berry Oncology Business Overview
11.11.3 Berry Oncology Single Cancer Screening Introduction
11.11.4 Berry Oncology Revenue in Single Cancer Screening Business (2019-2024)
11.11.5 Berry Oncology Recent Development
11.12 Shanghai Kunyuan Biotechnology
11.12.1 Shanghai Kunyuan Biotechnology Company Details
11.12.2 Shanghai Kunyuan Biotechnology Business Overview
11.12.3 Shanghai Kunyuan Biotechnology Single Cancer Screening Introduction
11.12.4 Shanghai Kunyuan Biotechnology Revenue in Single Cancer Screening Business (2019-2024)
11.12.5 Shanghai Kunyuan Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Single Cancer Screening Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Colorectal Cancer
 Table 3. Key Players of Liver Cancer
 Table 4. Key Players of Lung Cancer
 Table 5. Key Players of Other
 Table 6. Global Single Cancer Screening Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Single Cancer Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Single Cancer Screening Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Single Cancer Screening Market Share by Region (2019-2024)
 Table 10. Global Single Cancer Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Single Cancer Screening Market Share by Region (2025-2030)
 Table 12. Single Cancer Screening Market Trends
 Table 13. Single Cancer Screening Market Drivers
 Table 14. Single Cancer Screening Market Challenges
 Table 15. Single Cancer Screening Market Restraints
 Table 16. Global Single Cancer Screening Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Single Cancer Screening Market Share by Players (2019-2024)
 Table 18. Global Top Single Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cancer Screening as of 2023)
 Table 19. Ranking of Global Top Single Cancer Screening Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Single Cancer Screening Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Single Cancer Screening, Headquarters and Area Served
 Table 22. Global Key Players of Single Cancer Screening, Product and Application
 Table 23. Global Key Players of Single Cancer Screening, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Single Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Single Cancer Screening Revenue Market Share by Type (2019-2024)
 Table 27. Global Single Cancer Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Single Cancer Screening Revenue Market Share by Type (2025-2030)
 Table 29. Global Single Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Single Cancer Screening Revenue Market Share by Application (2019-2024)
 Table 31. Global Single Cancer Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Single Cancer Screening Revenue Market Share by Application (2025-2030)
 Table 33. North America Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Single Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Single Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Single Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Single Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Single Cancer Screening Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Single Cancer Screening Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Single Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Single Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Single Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Single Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Single Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Grail Company Details
 Table 49. Grail Business Overview
 Table 50. Grail Single Cancer Screening Product
 Table 51. Grail Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 52. Grail Recent Development
 Table 53. Exact Sciences Company Details
 Table 54. Exact Sciences Business Overview
 Table 55. Exact Sciences Single Cancer Screening Product
 Table 56. Exact Sciences Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 57. Exact Sciences Recent Development
 Table 58. Oncognostic Company Details
 Table 59. Oncognostic Business Overview
 Table 60. Oncognostic Single Cancer Screening Product
 Table 61. Oncognostic Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 62. Oncognostic Recent Development
 Table 63. Epigenomics Company Details
 Table 64. Epigenomics Business Overview
 Table 65. Epigenomics Single Cancer Screening Product
 Table 66. Epigenomics Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 67. Epigenomics Recent Development
 Table 68. Abbott Company Details
 Table 69. Abbott Business Overview
 Table 70. Abbott Single Cancer Screening Product
 Table 71. Abbott Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 72. Abbott Recent Development
 Table 73. Qiagen Company Details
 Table 74. Qiagen Business Overview
 Table 75. Qiagen Single Cancer Screening Product
 Table 76. Qiagen Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 77. Qiagen Recent Development
 Table 78. iStat Biomedical Company Details
 Table 79. iStat Biomedical Business Overview
 Table 80. iStat Biomedical Single Cancer Screening Product
 Table 81. iStat Biomedical Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 82. iStat Biomedical Recent Development
 Table 83. Genetron Health Company Details
 Table 84. Genetron Health Business Overview
 Table 85. Genetron Health Single Cancer Screening Product
 Table 86. Genetron Health Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 87. Genetron Health Recent Development
 Table 88. New Horizon Health Company Details
 Table 89. New Horizon Health Business Overview
 Table 90. New Horizon Health Single Cancer Screening Product
 Table 91. New Horizon Health Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 92. New Horizon Health Recent Development
 Table 93. Burning Rock Company Details
 Table 94. Burning Rock Business Overview
 Table 95. Burning Rock Single Cancer Screening Product
 Table 96. Burning Rock Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 97. Burning Rock Recent Development
 Table 98. Berry Oncology Company Details
 Table 99. Berry Oncology Business Overview
 Table 100. Berry Oncology Single Cancer Screening Product
 Table 101. Berry Oncology Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 102. Berry Oncology Recent Development
 Table 103. Shanghai Kunyuan Biotechnology Company Details
 Table 104. Shanghai Kunyuan Biotechnology Business Overview
 Table 105. Shanghai Kunyuan Biotechnology Single Cancer Screening Product
 Table 106. Shanghai Kunyuan Biotechnology Revenue in Single Cancer Screening Business (2019-2024) & (US$ Million)
 Table 107. Shanghai Kunyuan Biotechnology Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Single Cancer Screening Picture
 Figure 2. Global Single Cancer Screening Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Single Cancer Screening Market Share by Type: 2023 VS 2030
 Figure 4. Colorectal Cancer Features
 Figure 5. Liver Cancer Features
 Figure 6. Lung Cancer Features
 Figure 7. Other Features
 Figure 8. Global Single Cancer Screening Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Single Cancer Screening Market Share by Application: 2023 VS 2030
 Figure 10. Hospital Case Studies
 Figure 11. Physical Examination Center Case Studies
 Figure 12. Other Case Studies
 Figure 13. Single Cancer Screening Report Years Considered
 Figure 14. Global Single Cancer Screening Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Single Cancer Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Single Cancer Screening Market Share by Region: 2023 VS 2030
 Figure 17. Global Single Cancer Screening Market Share by Players in 2023
 Figure 18. Global Top Single Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cancer Screening as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Single Cancer Screening Revenue in 2023
 Figure 20. North America Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Single Cancer Screening Market Share by Country (2019-2030)
 Figure 22. United States Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Single Cancer Screening Market Share by Country (2019-2030)
 Figure 26. Germany Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Single Cancer Screening Market Share by Region (2019-2030)
 Figure 34. China Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Single Cancer Screening Market Share by Country (2019-2030)
 Figure 42. Mexico Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Single Cancer Screening Market Share by Country (2019-2030)
 Figure 46. Turkey Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Single Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Grail Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 50. Exact Sciences Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 51. Oncognostic Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 52. Epigenomics Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 53. Abbott Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 54. Qiagen Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 55. iStat Biomedical Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 56. Genetron Health Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 57. New Horizon Health Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 58. Burning Rock Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 59. Berry Oncology Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 60. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Single Cancer Screening Business (2019-2024)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture